Order Article Reprints

Hsu J-T, Hsu P-I, Shie C-B, Chuah S-K, Wu I-T, Huang W-W, Tang S-Y, Tsai K-F, Kuo L-F, Ghose S, et al. Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users. Medicina. 2022; 58(3):436. https://doi.org/10.3390/medicina58030436

Hsu, Jui-Ting, Ping-I Hsu, Chang-Bih Shie, Seng-Kee Chuah, I-Ting Wu, Wen-Wei Huang, Sheng-Yeh Tang, Kun-Feng Tsai, Li-Fu Kuo, Supratip Ghose, and et al. 2022. "Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users" Medicina 58, no. 3: 436. https://doi.org/10.3390/medicina58030436

Hsu, J.-T., Hsu, P.-I., Shie, C.-B., Chuah, S.-K., Wu, I.-T., Huang, W.-W., Tang, S.-Y., Tsai, K.-F., Kuo, L.-F., Ghose, S., Hsu, J.-C., & Shih, C.-A. (2022). Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users. Medicina, 58(3), 436. https://doi.org/10.3390/medicina58030436